Search Results 1771-1780 of 18227 for sickle cell
— Mayo Clinic researchers have identified a drug-and-supplement combination therapy that is capable of reducing the harmful effects of senescent cells – also[..
ROCHESTER, Minn. — In a new multicenter international study led by the Mayo Clinic Comprehensive Cancer Center, researchers found that people with the B-cell ...
A new tool to find hidden 'zombie cells' featured image · Mayo Clinic study sheds light on colorectal cancer risk in overlooked group featured image · New genomic ...
Preparing to biomanufacture a new CAR-T cell therapy for B-cell cancers featured. Research. Preparing to biomanufacture a new CAR-T cell therapy for B-cell ...
ROCHESTER, Minn. — Mayo Clinic researchers have discovered a key reason some cancer patients relapse after receiving chimeric antigen receptor T-cell therapy, ...
Mayo Clinic researchers will jump four hurdles to apply chimeric antigen receptor-T cell therapy (CAR-T cell therapy) to solid tumors in thyroid cancer.
(Video animation shows blood stem cells dividing and multiplying. Getty Images). Deep inside the body, a slow-growing cluster of mutated blood cells can form.
... cell lymphoma 2 (BCL2) inhibitor. ... Durvalumab is FDA approved for treatment in lung cancers including non-small cell lung cancer and small cell lung cancer.
Mayo Clinic does not endorse companies or products. Advertising revenue supports our not-for-profit mission.
Check out these best-sellers and special offers on books and newsletters from Mayo Clinic Press.
Hurry to 3X your gift’s impact on cancer research and care!